Literature DB >> 14580770

Deletions of 17p are associated with transition from early to advanced colorectal cancer.

Mauro Risio1, Laura Casorzo, Laura Chiecchio, Giovanni De Rosa, Francesco Paolo Rossini.   

Abstract

Several chromosome defects parallel morphologic evolution in colorectal tumor progression. Allelic losses in the short arm of chromosome 17, the majority encompassing the 17p13.3 band, have been found in advanced cancer in the absence of TP53 mutations, suggesting that loss of genes in this chromosome region is relevant for tumorigenesis. The aim of this study was to investigate 17p13.3 deletions throughout the colorectal tumor progression using two-color fluorescence in situ hybridization. Histologic sections from 20 colorectal adenomas containing early invasive carcinoma were analyzed by interphase fluorescence in situ hybridization using a centromeric probe for chromosome 17 simultaneously with a subtelomeric probe mapping to the 17p13.3 band. Separate evaluation was made for sectors corresponding to adenoma tissue with low-grade dysplasia, high-grade dysplasia, and early cancer. The same technique was also used in 20 cases of advanced adenocarcinoma of the large bowel. Loss of one centromeric signal was observed in 20, 40, 50, and 10% of low-grade dysplasia, high-grade dysplasia, early cancer, and advanced cancer, respectively (P<0.02 early vs. advanced cancer). Subtelomeric 17p deletions were seen in 60% of advanced cancer and in 15% of early cancer (P<0.01). These findings indicate that loss of genes from the 17p13.3 chromosome region may play an important role in sustaining the transition from early to advanced cancer in colorectal tumor progression.

Entities:  

Mesh:

Year:  2003        PMID: 14580770     DOI: 10.1016/s0165-4608(03)00188-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma.

Authors:  Jens K Habermann; Constanze A Brucker; Sandra Freitag-Wolf; Kerstin Heselmeyer-Haddad; Stefan Krüger; Linda Barenboim; Tricia Downing; Hans-Peter Bruch; Gert Auer; Uwe J Roblick; Thomas Ried
Journal:  Mod Pathol       Date:  2010-11-19       Impact factor: 7.842

Review 2.  Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.

Authors:  Elaine S Tan; Todd C Knepper; Xuefeng Wang; Jennifer B Permuth; Liang Wang; Jason B Fleming; Hao Xie
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

Review 3.  The natural history of colorectal adenomas and early cancer.

Authors:  M Risio
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

4.  The Natural History of pT1 Colorectal Cancer.

Authors:  Mauro Risio
Journal:  Front Oncol       Date:  2012-03-05       Impact factor: 6.244

5.  Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.

Authors:  Andrea Luchetti; Diana Walsh; Fay Rodger; Graeme Clark; Tom Martin; Richard Irving; Mario Sanna; Masahiro Yao; Mercedes Robledo; Hartmut P H Neumann; Emma R Woodward; Farida Latif; Stephen Abbs; Howard Martin; Eamonn R Maher
Journal:  Int J Endocrinol       Date:  2015-03-25       Impact factor: 3.257

6.  Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.

Authors:  María González-González; Luís Muñoz-Bellvis; Carlos Mackintosh; Celia Fontanillo; M Laura Gutiérrez; M Mar Abad; Oscar Bengoechea; Cristina Teodosio; Emilio Fonseca; Manuel Fuentes; Javier De Las Rivas; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

7.  Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Authors:  Yujing Li; Yunhua Liu; Hanchen Xu; Guanglong Jiang; Kevin Van der Jeught; Yuanzhang Fang; Zhuolong Zhou; Lu Zhang; Michael Frieden; Lifei Wang; Zhenhua Luo; Milan Radovich; Bryan P Schneider; Yibin Deng; Yunlong Liu; Kun Huang; Bin He; Jin Wang; Xiaoming He; Xinna Zhang; Guang Ji; Xiongbin Lu
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.